Charting New Territories in Kinase Drug Discovery

Confluence Life Sciences seeks to partner its product candidates and KINect™ Technology Platform through the following types of partnerships:

  • Licensing agreements as Confluence’s product candidates reach value inflection points such as candidate selection, IND-ready or clinical proof-of-concept
  • Drug discovery collaboration and license arrangements for single or multiple targets that have been identified either independently by the partner or in collaboration with Confluence based on our insights regarding biologically-interesting disease targets and for which use of the KINect™ Technology Platform can be enabling

For further information on Confluence’s programs and technology,

please contact